NEW YORK (GenomeWeb News) – Vancouver, BC-based molecular diagnostics firm Response Biomedical today announced the signing of a subscription agreement for the sale of C$8 million ($7.7 million) of its common shares to investment company OrbiMed Advisor's affiliated Asia fund.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.